Wednesday, February 27, 2008

US: Pfizer and Apotex settle on Gabapentin

Apotex and Pfizer have settled all litigations pertaining to gabapentin [Neurontin] capsules and tablets. Though terms of the settlement are confidential, Apotex said that it is free to market and sell the generic version as it has done since April 2005.
The agreement ends almost a decade of litigation between the two companies.

Pfizer has aggressively litigated on gabapentin against a whole load of companies and in 2005, the federal district court in New Jersey ruled that Pfizer was unable to prove infringement of its Neurontin patents by generic drug makers including Alpharma, Apotex, Teva and Eon Labs.

In September 2007, an appeals court overturned portions of the 2005 decision and sent the case to a new trial after ruling that the district court erred in granting summary judgment of non-infringement [advantage Pfizer :-) ]. Then, Pfizer had said that it planned to pursue full damages due to the so-called at-risk launch of generic versions of Neurontin, the patent for which doesn't expire until 2017.

Link to earlier post on gabapentin litigation, here.

2 comments:

JaaJoe said...
This post has been removed by a blog administrator.
viagra said...

As soon as Viagra was introduced in the pharmaceutical market in 1998, the little blue pill tremendously helped men worldwide to trigger off erections necessary for sexual intercourse and with Viagra working for men across the world; they were far from being affected by erectile dysfunction. So, if you are also suffering from erectile dysfunction, you can use Viagra and get rid of the sexual disorder. But before administering Viagra, come in touch with http://www.viagraforce.com for once and get hold of relevant Viagra information.

 
GoStats hit counter
GoStats hit counter